Cite
HARVARD Citation
Gow, C. et al. (2015). Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib. Journal of thoracic oncology. 10 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gow, C. et al. (2015). Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib. Journal of thoracic oncology. 10 (7), p. . [Online].